BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 6432902)

  • 41. Phorbol ester-inactivation of cloned cytotoxic T lymphocytes: restoration of lytic activity by interleukin 2 and induction of interferon production are separable events.
    Finke JH; Yen-Lieberman B; Scott JW; Proffitt MR; Orosz CG
    Lymphokine Res; 1985; 4(4):299-308. PubMed ID: 3930891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab')2 fragment of anti-CD16 antibody.
    Jewett A; Teruel A; Romero M; Head C; Cacalano N
    Cancer Immunol Immunother; 2008 Jul; 57(7):1053-66. PubMed ID: 18188563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cells.
    Keler T; Graziano RF; Mandal A; Wallace PK; Fisher J; Guyre PM; Fanger MW; Deo YM
    Cancer Res; 1997 Sep; 57(18):4008-14. PubMed ID: 9307286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
    Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
    J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
    Zollner TM; Zhu HG; Anderer FA
    Anticancer Res; 1993; 13(4):923-30. PubMed ID: 8352560
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amentoflavone, a biflavonoid from Biophytum sensitivum augments lymphocyte proliferation, natural killer cell and antibody dependent cellular cytotoxicity through enhanced production of IL-2 and IFN-gamma and restrains serum sialic acid and gamma glutamyl transpeptidase production in tumor - bearing animals.
    Guruvayoorappan C; Kuttan G
    J Exp Ther Oncol; 2007; 6(4):285-95. PubMed ID: 18038762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phorbol ester modulation of T-cell antigens in the Jurkat lymphoblastic leukemia cell line.
    Cassel DL; Hoxie JA; Cooper RA
    Cancer Res; 1983 Oct; 43(10):4582-6. PubMed ID: 6603901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phorbol esters specifically inhibit induction of immunoglobulin secretion in a murine B cell leukemia.
    Simpson LG; Isakson PC
    J Immunol; 1985 Apr; 134(4):2759-66. PubMed ID: 3871817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antagonistic effects of interferons on the cytotoxicity mediated by natural killer cells.
    Trinchieri G; Santoli D; Granato D; Perussia B
    Fed Proc; 1981 Oct; 40(12):2705-10. PubMed ID: 6169557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes.
    Melero I; Salmerón A; Balboa MA; Aramburu J; López-Botet M
    J Immunol; 1994 Feb; 152(4):1662-73. PubMed ID: 8120376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane.
    Perussia B; Acuto O; Terhorst C; Faust J; Lazarus R; Fanning V; Trinchieri G
    J Immunol; 1983 May; 130(5):2142-8. PubMed ID: 6339622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phorbol ester-stimulated T lymphocytes show enhanced adhesion to human endothelial cell monolayers.
    Haskard D; Cavender D; Ziff M
    J Immunol; 1986 Sep; 137(5):1429-34. PubMed ID: 3091681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transient modulation and internalization of T4 antigen induced by phorbol esters.
    Hoxie JA; Matthews DM; Callahan KJ; Cassel DL; Cooper RA
    J Immunol; 1986 Aug; 137(4):1194-201. PubMed ID: 3090141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes.
    Nair MP; Schwartz SA
    J Immunol; 1984 Jun; 132(6):2876-82. PubMed ID: 6202765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specific spontaneous cytotoxic activity in human T cell colonies.
    Price GB; Teh HS; Miller RG
    J Immunol; 1980 May; 124(5):2352-5. PubMed ID: 6767786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro.
    Iho S; Yamamoto T; Takahashi T; Yamamoto S
    J Immunol; 1999 Oct; 163(7):3642-52. PubMed ID: 10490958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
    Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
    Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.